Madrigal Pharmaceuticals Inc (MDGL) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Madrigal Pharmaceuticals Inc.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 13 | $225 | $126 | $171.54 | $116.59 | 47.13% |
The Trend in the Analyst Price Target
Over the past 56 days, MDGL's average price target has gone up $1.54.
Over the past 304 days, MDGL's average upside potential has been 48.79%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2020-06-03 | 14 | 300 | 104 | 174.14 | 110.32 | 57.85% |
| 2020-06-11 | 14 | 300 | 104 | 174.14 | 104.37 | 66.85% |
| 2020-07-14 | 13 | 300 | 104 | 172.85 | 103.41 | 67.15% |
| 2020-07-21 | 13 | 230 | 104 | 167.46 | 108.86 | 53.83% |
| 2020-08-06 | 14 | 230 | 114 | 169.86 | 103.10 | 64.75% |
| 2020-08-07 | 14 | 230 | 114 | 169.64 | 105.25 | 61.18% |
| 2020-08-16 | 13 | 230 | 114 | 172.92 | 106.49 | 62.38% |
| 2020-09-01 | 14 | 230 | 114 | 170.79 | 106.09 | 60.99% |
| 2020-09-17 | 15 | 230 | 114 | 171.80 | 118.20 | 45.35% |
| 2020-10-03 | 15 | 230 | 114 | 172.67 | 116.52 | 48.19% |
| 2020-10-21 | 15 | 230 | 114 | 172.67 | 127.09 | 35.86% |
| 2020-11-10 | 15 | 230 | 123 | 173.73 | 130.01 | 33.63% |
| 2020-11-20 | 15 | 230 | 123 | 171.07 | 114.87 | 48.92% |
| 2020-12-07 | 14 | 230 | 123 | 170.00 | 120.83 | 40.69% |
| 2020-12-09 | 14 | 230 | 123 | 170.00 | 119.09 | 42.75% |
| 2020-12-19 | 14 | 230 | 123 | 170.00 | 117.12 | 45.15% |
| 2020-12-26 | 14 | 230 | 123 | 170.00 | 120.12 | 41.53% |
| 2021-01-02 | 14 | 230 | 123 | 170.00 | 111.17 | 52.92% |
| 2021-01-09 | 14 | 230 | 123 | 170.00 | 115.59 | 47.07% |
| 2021-01-16 | 14 | 230 | 123 | 170.00 | 109.04 | 55.91% |
| 2021-01-23 | 14 | 230 | 123 | 170.00 | 116.95 | 45.36% |
| 2021-01-30 | 14 | 230 | 123 | 170.00 | 118.76 | 43.15% |
| 2021-02-06 | 14 | 230 | 123 | 170.00 | 120.50 | 41.08% |
| 2021-02-13 | 14 | 230 | 123 | 170.00 | 122.23 | 39.08% |
| 2021-02-20 | 14 | 230 | 123 | 170.00 | 121.88 | 39.48% |
| 2021-02-27 | 14 | 225 | 126 | 170.29 | 121.19 | 40.51% |
| 2021-03-06 | 14 | 225 | 126 | 170.07 | 116.28 | 46.26% |
| 2021-03-13 | 14 | 225 | 126 | 170.36 | 117.84 | 44.57% |
| 2021-03-20 | 13 | 225 | 126 | 171.54 | 117.08 | 46.52% |
| 2021-04-03 | 13 | 225 | 126 | 171.54 | 118.58 | 44.66% |
MDGL Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.57 | 3 | 8 | 3 | 0 | 0 | 15 |
The Trend in the Broker Recommendations
list("500 - Internal server error")
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for MDGL as an investment opportunity.
- Madrigal Pharmaceuticals Inc's average analyst price target is greater than 92.76% of all US stocks.
- The number of analysts covering the stock of MDGL is greater than 91.06% of Pharmaceutical Products stocks.
- Madrigal Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is greater than 88.5% of stocks in the mid market cap category.
- The variance in analysts' estimates of MDGL is lower than 19.49% of stocks in the mid market cap category.
Stocks similar to Madrigal Pharmaceuticals Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are MRTX, ARWR and PCRX.
Is MDGL a Buy, Hold or Sell? See the POWR Ratings now!